| |
|
|
|
Cytomx Thera  
|
|
7.13 -0.47 (-0.06%) |
03-05 10:36 |
|
Open: |
7.66 |
Pre close: |
7.6 |
Target:
|
9.84
|
|
High: |
7.7 |
Low: |
7.06 |
Resistance:
|
8.43
9.42
|
|
Volume: |
171,745 |
Market Cap: |
462M |
Support:
|
6.82
5.67
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.03
 |
MACD |
MACD(12,26):
|
0.03 |
|
MA(20): |
8.33 |
Signal(12,26,9): |
0.15 |
|
MA(100): |
7.45  |
Stochastic Oscillator |
%K(14,3):
|
18.53 |
|
MA(250): |
7.77 |
%D(3): |
30.30 |
|
Average Volume(K) |
3-Month: |
93443
|
52-Week |
High:
|
15.44 |
|
10-Days: |
74710 |
Low: |
3.60 |
|
RSI |
RSI(14):
|
43.24 |
Change(%): |
22.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.170 |
Return on Equity (ttm) |
-82.4 |
Shares Out. (M) |
62.05 |
|
EPS Est. Current Year |
-1.490 |
Return on Assets (ttm) |
-11.9 |
Shares Float (M) |
36.81 |
|
EPS Est. Next Year |
-1.410 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.89 |
|
EPS Est. Next Quarter |
-0.410 |
Qtrly Rev. Growth |
66.1 |
% Held by Institutions |
83.50 |
|
Forward EPS |
-2.260 |
Gross Profit (p.s.) |
0.927 |
Shares Short (K) |
3010 |
|
Book Value (p.s.) |
1.040 |
EBITDA (p.s.) |
-1.107 |
P/E |
-6.46 |
|
Sales Per Share |
1.487 |
Qtrly Earnings Growth |
0.00 |
P/BV |
7.27 |
|
Profit Margin |
-58.13 |
Operating Cash Flow
(M) |
-6.79 |
P/S |
5.08 |
|
Operating Margin |
-77.17 |
Levered Free Cash Flow
(M) |
-13.71 |
P/CF |
-69.09 |
|
|
|
|
|
|
